发明名称 Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor.
摘要 <p>Macrophages and precursor monocytes are activated to exhibit tumoricidal activity by stimulation solely with granulocyte-macrophage colony stimulating factor. A patient suffering from tumors can be treated by direct administration of therapeutically effective quantities of activated granulocyte-macrophage colony stimulating factor. Homogeneous granulocyte-macrophage colony stimulating factor for use in activating macrophages and monocyte precursors is prepared by recombinant DNA techniques. The gene coding for granulocyte-macrophage colony stimulating factor is isolated and then recombinant protein product expressed in an appropriate expression system. The granulocyte-macrophage colony stimulating factor recovered from the expression system is purified to homogeneity by reverse phase high-performance liquid chromatography.</p>
申请公布号 EP0211684(A2) 申请公布日期 1987.02.25
申请号 EP19860306304 申请日期 1986.08.15
申请人 IMMUNEX CORPORATION 发明人 ANDERSON, DIRK M.;CANTRELL, MICHAEL A.;CERRETTI, DOUGLAS P.;CONLON, PAUL J., III;COSMAN, DAVID J.;GRABSTEIN, KENNETH H.;LARSEN, ALF D.;PRICE, VIRGINIA L.
分类号 A61K35/14;A61K35/12;A61K35/26;A61K35/74;A61K38/00;A61K38/16;A61P35/00;C07K14/535;C12N15/00;C12P21/02;(IPC1-7):A61K37/02 主分类号 A61K35/14
代理机构 代理人
主权项
地址